High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.

Evidence for association between paraoxonase-1 activity and diseases. Afr Health Sci (2013) 1.06

The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci (2012) 0.92

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation. Arch Med Sci (2013) 0.88

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity. J Res Med Sci (2012) 0.87

Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: relationship with low density lipoprotein oxidation. Lipids Health Dis (2012) 0.80

Exploring the role of paraoxonases in the pathogenesis of coronary artery disease: a systematic review. Int J Mol Sci (2014) 0.79

Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods. J Ocul Biol Dis Infor (2011) 0.78

Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease. Indian J Hum Genet (2014) 0.76

The Association between the Epicardial Adipose Tissue Thickness and Oxidative Stress Parameters in Isolated Metabolic Syndrome Patients: A Multimarker Approach. Int J Endocrinol (2014) 0.76

Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature (1998) 3.84

Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol (1979) 3.50

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest (1995) 3.23

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett (1991) 3.10

Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol (2001) 2.34

Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr (2000) 2.07

Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol (2003) 2.01

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation (2002) 1.96

Vitamin E analysis methods for animal tissues. Methods Enzymol (1984) 1.89

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med (1999) 1.80

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation (2003) 1.78

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation (2000) 1.61

Genetic polymorphism and interethnic variability of plasma paroxonase activity. J Med Genet (1976) 1.61

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol (1996) 1.48

Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol (1999) 1.42

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J (1993) 1.16

Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12

Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis (2001) 1.08

Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis (1992) 0.98

Arylesterase in serum: elaboration and clinical application of a fixed-incubation method. Clin Chem (1979) 0.91

Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus. J Clin Endocrinol Metab (2003) 0.82

Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem Funct (2004) 0.81

Distribution of cholesterol in HDL and its subfractions in patients with coronary atherosclerotic heart disease. Indian Heart J (1994) 0.78